Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Queensland Health
Accenture
Julphar
Daiichi Sankyo
Healthtrust
US Department of Justice
Merck
Fuji
Cipla

Generated: December 12, 2017

DrugPatentWatch Database Preview

Shire Llc Company Profile

« Back to Dashboard

What is the competitive landscape for SHIRE LLC, and when can generic versions of SHIRE LLC drugs launch?

SHIRE LLC has four approved drugs.

There are three US patents protecting SHIRE LLC drugs on SHIRE LLC drugs in the past three years.

There are ninety-five patent family members on SHIRE LLC drugs in thirty-five countries and three supplementary protection certificates in two countries.

Summary for Shire Llc

International Patents:95
US Patents:3
Tradenames:4
Ingredients:4
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-001Oct 26, 2004DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Shire LlcAGRYLINanagrelide hydrochlorideCAPSULE;ORAL020333-002Mar 14, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-002Oct 26, 2004ABRXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-004Nov 23, 2005ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-003Nov 23, 2005ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-003Nov 23, 2005ABRXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Shire LlcPROAMATINEmidodrine hydrochlorideTABLET;ORAL019815-002Sep 6, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Shire LlcAGRYLINanagrelide hydrochlorideCAPSULE;ORAL020333-001Mar 14, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-003Nov 23, 2005ABRXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Shire LlcSALURONhydroflumethiazideTABLET;ORAL011949-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for SHIRE LLC drugs

Drugname Dosage Strength Tradename Submissiondate
lanthanum carbonateOral Powder750 mg and 1000 mgFOSRENOL11/25/2015
lanthanum carbonateChewable Tablet500 mg, 750 mg and 1000 mgFOSRENOL10/27/2008

International Patent Family for Shire Llc Drugs

Country Document Number Estimated Expiration
Norway20082538► Subscribe
Germany202004021169► Subscribe
Denmark0817639► Subscribe
Slovenia2172205► Subscribe
United Kingdom9506126► Subscribe
Portugal2133084► Subscribe
South Korea100830764► Subscribe
Argentina056609► Subscribe
New Zealand303260► Subscribe
Estonia04096► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Shire Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2008005Lithuania► SubscribePRODCUT NAME: LANTANO KARBONATO HIDRATAS; NAT. REG. DATE/NO: LT/1/07/0776/001-021; FIRST REG. DATE: 20040319
2008005,C0817639Lithuania► SubscribePRODUCT NAME: LANTANO KARBONATO HIDRATAS; NAT. REGISTRATION NO/DATE: LT/1/07/0776/001-021 20071003; FIRST REGISTRATION: 17192, 2004-03-19 ; 18466, 2004-03-19; 21073, 2004-10-19; 21074 20041029
C/GB06/036United Kingdom► SubscribeSPC/GB06/036: 20061027
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Moodys
Boehringer Ingelheim
McKesson
Julphar
Cantor Fitzgerald
Chinese Patent Office
Daiichi Sankyo
Federal Trade Commission
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot